FXR ligand specificity is the important observation, considering the beneficial effects of FXR ligands in cholestasis and hypercholesterolemia (Jonker et al., 2012; Amano et al., 2018; Keitel et al., 2019). This evidence concerns the gene NR1H4 and cholestasis.